1、REPORTZS medical affairs outlook report 2024Achieving go-to-market success with next-gen medical affairsBy Sunil John and Sarah Jarvis 2024 ZS|1REPORTExecutive summaryAs the healthcare industry adapts to a new landscape,medical affairs organizations must stay attuned to the evolving needs and expect

2、ations of an increasingly diverse and expanding set of stakeholders.The 2024 ZS medical affairs outlook report sheds light on key insights and emerging trends,including advancements in the medical affairs domain,evolving go-to-market strategies,a growing emphasis on technology and clinical practice

3、changes.To gain a comprehensive understanding of the medical affairs ecosystem,the report analyzes the perspectives of both internal medical affairs professionals as well as external key opinion leaders(KOLs).By closely examining these varied viewpoints,the report aims to equip medical affairs leade

4、rs with the knowledge and foresight required to navigate the dynamic healthcare landscape and effectively engage with their expanding stakeholder base.As the industry continues to evolve,this holistic analysis provides critical guidance to help teams adapt and thrive.On average,a KOL takes three to

5、four actions after an MSL interaction.Additionally,almost half of KOLs said that they shared information with colleagues or switched their treatment or line of therapy following an MSL interaction.2024 ZS|2REPORTKey findingsAn analysis of this years survey data identified the following key trends:Ev

6、olution of medical affairs organizationsWhile most medical affairs organizations remain in a state of evolving organizational maturity,the percentage classifying themselves as best in class increased from 13%to 19%over the past year.Companies are focused on refining their strategic planning processe